How does a heart that pauses require a pacemaker (artificial pacemaker) in atrial fibrillation (AF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A pacemaker is recommended for patients with atrial fibrillation (AF) who experience symptomatic heart pauses, as it can significantly improve morbidity, mortality, and quality of life. When considering pacemaker implantation in patients with AF, it is essential to evaluate the frequency and duration of pauses, associated symptoms, and underlying heart conditions. According to the 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities 1, the choice of pacemaker generator depends on various factors, including the presence of atrioventricular block, carotid sinus hypersensitivity, and the need for rate response.

Key considerations for pacemaker implantation in AF patients include:

  • Symptomatic heart pauses lasting longer than 3-5 seconds
  • Associated symptoms such as dizziness, fainting, or fatigue
  • Underlying heart conditions, such as atrioventricular block or sinus node dysfunction
  • Overall health status and potential benefits of pacemaker therapy

In patients with AF and symptomatic heart pauses, a dual-chamber pacemaker with mode-switching capability may be the most suitable option, as it allows for atrioventricular synchrony during pacing and can adapt to changes in heart rhythm 1. The procedure involves placing a small electronic device under the skin of the chest or abdomen, with thin wires (leads) connecting to the heart chambers. The pacemaker then monitors the heart rhythm and sends electrical impulses when needed to maintain an appropriate heart rate. By prioritizing the most recent and highest quality study, we can ensure that patients with AF and symptomatic heart pauses receive the most effective and evidence-based treatment, ultimately improving their morbidity, mortality, and quality of life.

From the Research

Indications for Pacemaker Implantation in Atrial Fibrillation

  • Symptomatic prolonged sinus pauses on termination of atrial fibrillation (AF) are an accepted indication for pacemaker implantation 2, 3, 4
  • Pacing is indicated in patients with AF when clinical symptoms are readily attributable to slow ventricular rate and prolonged ventricular pauses 3

Role of Catheter Ablation in Patients with Paroxysmal Atrial Fibrillation and Prolonged Sinus Pauses

  • Catheter ablation has been reported to be a curative therapy for tachycardia-bradycardia syndrome without pacemaker implantation 2, 5
  • Successful ablation can eliminate both AF and prolonged sinus pauses in the majority of patients with tachycardia-bradycardia syndrome 5
  • AF ablation seems to be superior to a strategy of pacing plus antiarrhythmic drugs in patients with paroxysmal AF-related tachycardia-bradycardia syndrome 2

Prognosis of Prolonged Ventricular Pauses in Atrial Fibrillation

  • Prolonged ventricular pauses in AF are not a marker of poor prognosis in terms of mortality 6
  • However, pauses in patients referred to Holter due to syncope and/or dizzy spells are associated with an increased risk of pacemaker treatment 6

Effect of Ablation on Sinus Node Function

  • Prolonged sinus pauses after paroxysmal AF may result from depressed sinus node function, which can be eliminated by curative ablation of AF 4
  • The maximum sinus pause decreased significantly after ablation, and sinus pauses > 2.0 seconds disappeared after ablation in all patients 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses: outcome during a 5-year follow-up.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.